Statistics from Altmetric.com
RECENT developments in the disease situation surrounding Schmallenberg virus (SBV) in northern Europe are discussed in the latest outbreak assessment from the International Disease Monitoring (IDM) team at Defra.
In the assessment, which was published on April 23, the IDM team says that AHVLA laboratories are currently validating a serological ELISA that has become commercially available in Europe. Defra is considering how the test could be used for surveillance and whether there is a potential …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.